# A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

> **NCT00321997** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eyetech Pharmaceuticals** · enrollment: 540 (—)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Pegaptanib sodium

## Key facts

- **NCT ID:** NCT00321997
- **Lead sponsor:** Eyetech Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 540 (—)
- **Last updated:** 2006-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321997, "A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00321997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*